The scenario began with an alarming increase in out-of-specification (OOS) results recorded during post-manufacturing quality checks for a specific product batch following equipment changeovers. Operators reported unusual residue found on…
The manufacturing facility in question reported a series of deviations related to product contamination during routine operations. Specifically, several batches showed unexpected results in residual solvent testing after an equipment…
During a routine FDA inspection at a sterile manufacturing facility, clear signals indicated potential issues with cleaning validation protocols. Among the most prominent symptoms were:Click to read the full article.
Recognizing symptoms of a cleaning SOP deviation is crucial for early intervention. In this case, symptoms were first reported during routine quality control checks, which began to unveil potential issues:Click…
The first indication of potential contamination came during a routine GMP inspection when laboratory personnel identified foreign residues exceeding acceptable limits in a production area. Several key symptoms raised alarms:Click…
In our case study, the symptoms of the problem manifested during a planned changeover between production batches of different drug substances. The following signals were observed:Click to read the full…
The first indications of the cleaning SOP deviation surfaced during routine production monitoring. Operational staff noted the following symptoms:Click to read the full article.
Symptoms associated with the acceptance of visual cleanliness without testing became evident during routine inspections and bench-level evaluations. Key signals included:Click to read the full article.
The first indication of the issue came during routine quality control (QC) checks, where increased levels of residues from a previously manufactured product were detected in batch samples. Operators on…
The initial indication of potential cross-contamination was observed during routine quality control checks of drug products manufactured in the facility. The following symptoms were noted:Click to read the full article.
The situation unfolded when routine testing revealed residual cleaning agents and traces of prior products in equipment used for the formulation of a new drug. Quality Control (QC) personnel flagged…